Please note that this is the Draft programme of the EU HCV Summit. The programme will be updated on a regular basis.


Welcome address
Chairs: Prof. Michael P. Manns – Co-Chair HepBC PPA & Hannover Medical School,
Prof. Angelos Hatzakis – Co-Chair HepBC PPA & University of Athens Medical School

13:15-13:20 Welcome to event & scene-setting  – Prof. Angelos Hatzakis


Keynote address
Chair: Prof Michael P Manns, Co-Chair HepBC PPA & Hannover Medical School
Dr. Vytenis Andriukaitis
, European Commissioner for Health


Introductory remarks
Why HCV must and can be eliminated in Europe
Chairs: Prof. Michael P. Manns – Co-Chair HepBC PPA & Hannover Medical School, Prof. Angelos Hatzakis – Co-Chair HepBC PPA & University of Athens Medical School

13:35-13:40 Welcome & introductory remarks – Dr. Cristian-Silviu Buşoi, Member of the European Parliament and Co-Chair of the Friends of the Liver MEP Group

13:40-13:45 Introductory comments – Dr. Tatjana Reic, President, European Liver Patients Association

13:45-13:50 Introductory comments – Eberhard Schatz, Director, Correlation Network

13:50-13:55 Introductory comments – Prof. Helena Cortez-Pinto, EU Policy Councillor Elect, European Association for the Study of the Liver 


Session 1
A successful elimination strategy for HCV in Europe: current challenges and criteria for success

Chairs: Prof. Pierre Van Damme – Viral Hepatitis Prevention Board, Prof. Markus Peck-Radosavljevic – Klinikum Klagenfurt

13:55-14:05 The Burden of HCV in European Union – Dr. Homie Razavi, Center for Disease Analysis

14:05-14:15 Elimination of hepatitis and the first WHO Global Hepatitis Strategy – Dr. Stephan Wiktor, World Health Organisation

14:15-14:25 The cost of HCV elimination – Prof. Jagpreet Chhatwal, Massachusetts General Hospital & Harvard Medical School

14:25-14:35  Key elements of a successful elimination strategy from a patient perspective – Achim Kautz, European Liver Patients Association

14:35-14:45 The public health challenges that need to be overcome to eliminate HCV – John F. Ryan, European Commission

14:45-15:05 Panel debate moderated by Prof. Pierre Van Damme – Viral Hepatitis Prevention Board

Coffee Break


Session 2
Practical steps to eliminate HCV at national/local level (examples of existing good practice)

Chairs: Prof. Massimo Colombo - University of Milan, Prof. Nurdan Tözün - Acibadem University


- Prevention – Dr. Ingo Michels, Federal Ministry of Health, Germany

- Screening – Dr. Yazdan Yazdanpanah, Hôpital Bichat-Claude Bernard Paris, France

- Linkage to care – Prof. David Goldberg, Health Protection Scotland

- Harm reduction – Dr. Luís Mendão, Portuguese Activist Group for HIV/AIDS Treatment, Portugal

- Access to treatment – Dr. Ricardo Baptista Leite, Catholic University, Portugal

Political will – Dr. Freke Zuure, Amsterdam Public Health Service, The Netherlands

16:35–16:55 Panel discussion moderated by Prof. Massimo Colombo - University of Milan


Session 3
The role of EU and national policies in supporting the elimination of viral hepatitis in Europe (moderated panel debate)

Chairs: Prof. Heiner Wedemeyer – Hannover Medical School, Prof. George Papatheodoridis – University of Athens Medical School


-        Action plan for the prevention and control of viral hepatitis in the WHO European Region 2016–2021 – Dr. Antons Mozalevskis, WHO Europe

-        ECDC’s priorities for supporting EU/EEA countries in their plans to eliminate HCV – Dr. Erika Duffell, European Centre for Disease Prevention and Control

-        HCV among people who inject drugs: harm reduction, screening and treatment for a successful strategy – Alexis Goosdeel, European Monitoring Centre for Drugs and Drug Addiction

-        The role of national and EU policies from the Greek perspective – Dr. Ioannis Baskozos, Ministry of Health, Greece 

17:35-17:55 Panel debate moderated by Charles Gore – World Hepatitis Alliance & Co-Chair HepBC PPA


Official presentation of the HCV Elimination Manifesto
Chair: Prof. Antonio Craxi, University of Palermo

Presentation by: Prof. Jeffrey Lazarus - Centre for Health and Infectious Disease Research, Prof. Pierre Van Damme – Viral Hepatitis Prevention Board


18:15 - 18:25

Wrap up and concluding remarks

Prof. Michael P. Manns, Hannover Medical School

The 1st high-level European Policy Summit on the elimination of the Hepatitis C Virus (HCV) in Europe is being organised by the Hepatitis B&C Public Policy Association.

The HCV Policy Summit will take place on Wednesday, 17th February 2016 from 1.30pm to 6.30pm.

The venue for the Summit is the Bibliothèque Solvay, Parc Léopold, Belliardstraat 137, 1040 Brussels. For more information about the Bibliothèque Solvay, please see the link Venue.

The summit will be followed by a networking dinner at the Stanhope hotel, which is within walking distance of the event venue. The address is Handelsstraat 9, 1000 Brussels.

Participation at the Summit is by invitation only. If you would like to attend this event, please send an email to the Summit Administrative Secretariat: Ms Ann Fox at This email address is being protected from spambots. You need JavaScript enabled to view it.

Please note that registration for the Summit is not possible on this website.